Prediction Of QcrB Inhibition As A Measure Of Antitubercular Activity With Machine Learning Protocols.

09 March 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Mycobacterium tuberculosis has been a challenging target with respect to developing interventional therapies. Over the years, several attempts at developing anti-tubercular agents have hit a dead-end due to the propensity of the tubercular bacilli to mutate rapidly. Recently, cytochrome bcc complex (QcrB) has shown some promise as a novel target of the tubercular bacilli; with Q203 being the first molecule acting on this target. In this paper, we report the deployment of several ML-based approaches to design molecules against QcrB. Machine Learning (ML) models were developed based on a large dataset of 350 molecules using three different sets of molecular features, i.e. MACCS keys, ECFP6 fingerprints and Mordred descriptors. Each feature set was trained on eight ML classifier algorithms and optimised to classify molecules accurately. Of the 24 models generated, the best performing model was one built with support vector machine and based on the ECFP6 feature set. A further screening of the known imidazopyridine amide inhibitors demonstrated that the model correctly classified the most potent molecules as actives. Thus validating the model for future applications.

Keywords

Machine Learning
Q203
Antitubercular
imidazopyridine amides
QcrB inhibitors

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.